Brief: Sernova Receives Us Fda Ind Allowance To Initiate A Us Clinical Trial Of Its Cell Pouch
11/12/2017 11:00
Dec 11 (Reuters) - Sernova Corp SVA.V :
* SERNOVA RECEIVES US FDA IND ALLOWANCE TO INITIATE A US
CLINICAL
TRIAL OF ITS CELL POUCH FOR THE TREATMENT OF TYPE 1 DIABETES
* SERNOVA- PLANS TO INITIATE CLINICAL TRIAL UNDER US IND TO
INVESTIGATE CELL POUCH FOR TREATING TYPE 1 DIABETES IN PERSONS
WITH HYPOGLYCEMIA UNAWARENESS
Source text for Eikon: ID:nGNXOJVXWa
Further company coverage: SVA.V
(((Bangalore.newsroom@thomsonreuters.com);))
Recent news on Sernova Biotherapeutics
See all newsBrief: Seraxis And Sernova Announce Appointment Of Former FDA Medical Officer Dr. Patricia Beaston As Chief Medical Officer Of Seraxis And Post Merger Betanova Biotherapeutics
Brief: Sernova Appoints Jonathan Rigby As Interim Chair
Brief: Sernova Biotherapeutics Provides Positive Interim Data From Ongoing Phase 1/2 Clinical Trial Of Cell Pouch Bio-Hybrid Organ In Patients Living With Type 1 Diabetes
Brief: Sernova Biotherapeutics Secures $4 Million Loan To Further Advance Its Clinical Development Plans
Brief: Sernova Biotherapeutics Inc Study Is On Track To Meet Key Clinical Trial Endpoints